We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

News   Apr 30, 2018 | Original story from Rockefeller University Press

 
MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

Compared with control animals (left), the spinal cords of rats treated with bortezomib (center) contain increased numbers of activated astrocytes (green) that cause neuropathic pain. Bortezomib's effects are prevented by the multiple sclerosis drug fingolimod (right), which inhibits the sphingolipid metabolite receptor S1PR1. Credit: Stockstill et al., 2018

 
 
Advertisement
 

RELATED ARTICLES

Team Identifies Potential Drug Target for Severe E. coli Infections

News

UNSW Science researchers have studied an E. coli strain responsible for a severe intestinal infection in humans, enterohemorrhagic E. coli (EHEC). They have discovered a new molecular pathway that controls Shiga toxin production, this finding is important because there is no commercially available treatment for EHEC infections currently.

READ MORE

Compound Found in Blueberries Could Help Treat Inflammatory Diseases

News

Various plants and their products are known to contain "bioactive" ingredients that can alleviate human diseases. These "phytocompounds" often contain restorative biological properties such as anti-cancerous, antioxidant, and anti-inflammatory effects. A team of researchers at Tokyo University of Science has been working this direction for the past several years, to identify novel active components in functional foods and understand their effects on the body.

READ MORE

Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection

News

A Phase III, randomized, double-blinded, placebo-controlled trial will help to determine if the dual-antibody treatment, REGN-COV2, can prevent infection in individuals who share a home with someone who has been diagnosed with COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE